Columbus McKinnon Corp: Form 10-Q for the period ended Sep 30, 2024
Filed with the SEC on Oct 30, 2024 and accepted by EDGAR at Oct 30, 2024, 16:16 ET.
Management's discussion and analysis
As filed, 22,774 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
Executive Overview
The Company is a leading worldwide designer, manufacturer and marketer of intelligent motion solutions, including motion control products, technologies, automated systems and services, that efficiently and ergonomically move, lift, position and secure materials. Our key products include hoists, crane components, precision conveyors, actuators, rigging tools, light rail workstations, and digital power and motion control systems. These are highly relevant, professional-grade solutions that solve customers’ critical material handling requirements.
Founded in 1875, we have grown to our current size and leadership position through organic growth and acquisitions. We developed our leading market position over our 150-year history by emphasizing technological innovation, manufacturing excellence and superior customer service. In accordance with our strategic framework, we are building out our business system (CMBS) and growth framework to be market-led, customer-centric, and operationally excellent with our people and values at the core. We believe this will transform Columbus McKinnon into a top-tier Intelligent Motion Solutions company. We expect our strategy will enhance shareholder value by expanding EBITDA margins and return on invested capital ("ROIC").
Our revenue base is geographically diverse with approximately 45% of net sales derived from customers outside the U.S. for the six months ended September 30, 2024. We believe this diversity balances the impact of changes that occur in local economies, as well as benefits the Company by providing access to growing emerging markets. We monitor both U.S. and Eurozone Industrial Capacity Utilization statistics as well as the ISM Production Index as indicators of anticipated demand for our products. In addition, we continue to monitor the potential impact of other global and U.S. trends including, industrial production, trade tariffs, raw material cost inflation, interest rates, foreign currency exchange rates, and activity of end-user markets around the globe.
From a strategic perspective, we are investing in new products as we focus on our greatest opportunities for growth. We maintain a strong North American market share with significant leading market positions in hoists, lifting and sling chain, forged attachments, actuators, precision conveyors and digital power and motion control systems for the material handling industry. We seek to maintain and enhance our market share by focusing our sales and marketing activities toward select North American and global market sectors including general industrial, energy, automotive, heavy OEM, entertainment, construction and infrastructure, life sciences food and beverage, e-commerce and battery production.
In fiscal 2024, the Company acquired montratec GmbH ("montratec"), a leading automation solutions company that designs and develops intelligent automation and transport systems for interlinking industrial production and logistics processes. montratec product offerings compliment the previous acquisitions of both Dorner and Garvey, and these acquisitions are collectively expected to accelerate the Company’s shift into a provider of intelligent motion solutions and serve as a platform to expand capabilities in advanced, higher technology automation solutions.
Regardless of the economic climate and point in the economic cycle, we constantly explore ways to increase operating margins as well as further improve our productivity and competitiveness. We have specific initiatives to reduce lead-times, improve on-time deliveries, reduce warranty costs, and improve material and factory productivity. The initiatives are being driven by the implementation of our business operating system, CMBS. We are working to achieve these strategic initiatives through business simplification, operational excellence, and profitable growth initiatives. We believe these initiatives will enhance future operating margins.
Our principal raw materials and components purchases were approximately $396 million in fiscal 2024 (or 62% of Cost of product sold) and include steel, consisting of rod, wire, bar, structural, and other forms of steel; electric motors; bearings; gear reducers; castings; steel and aluminum enclosures and wire harnesses; electro-mechanical components; and standard variable drives and controls. These commodities are all available from multiple sources. We purchase most of these raw materials and components from a limited number of strategic and preferred suppliers under agreements which are negotiated on a Company-wide basis through our global purchasing group. While we are still experiencing some availability issues for select raw materials and components, we are working with our supply base to prioritize shipments and improve availability of key components.
We operate in a highly competitive and global business environment. We see a variety of opportunities in our markets and geographies, including trends toward automation and increasing labor productivity and the expansion of market opportunities in Asia and other emerging markets. While we execute our long-term growth strategy, we are supported by our strong free cash flow as well as our liquidity position and flexible debt structure.
Results of Operations
Three months ended September 30, 2024 and September 30, 2023
Net sales in the three months ended September 30, 2024 were $242,274,000, a decrease of $16,126,000 or 6.2% from the three months ended September 30, 2023 net sales of $258,400,000. Net sales were positively impacted by $3,796,000 due to price increases, offset by $20,169,000 of unfavorable sales volume. Foreign currency translation favorably impacted sales by $247,000 for the three months ended September 30, 2024.
Gross profit in the three months ended September 30, 2024 was $74,743,000, a decrease of $25,233,000 or 25.2% from the three months ended September 30, 2023 gross profit of $99,976,000. Gross profit margin was 30.9% in the fiscal 2025 second quarter compared to 38.7% in the fiscal 2024 second quarter. The decrease in gross profit was due to start-up costs totaling $2,185,000 related to the Monterrey, Mexico facility, $10,763,000 of asset impairment and other costs related to the closure of our Charlotte Manufacturing Operations and $12,302,000 of lower gross profit due to lower sales volumes. In addition, we incurred $171,000 of additional costs due to Hurricane Helene's impact on one of our facilities and $76,000 of net business realignment costs. These were offset by $97,000 of price increases net of material inflation and other manufacturing costs changes. The translation of foreign currencies had a $167,000 favorable impact on gross profit in the three months ended September 30, 2024.
Selling expenses were $26,926,000 and $26,867,000, or 11.1% and 10.4% of net sales, in the fiscal 2025 and 2024 second quarters, respectively. Foreign currency translation had an $18,000 unfavorable impact on selling expenses in the three months ended September 30, 2024.
General and administrative expenses were $23,363,000 and $25,709,000, or 9.6% and 9.9% of net sales, in the three months ended September 30, 2024 and 2023, respectively. General and administrative expenses decreased due to lower employee related costs of $3,706,000 compared to the prior year and $508,000 of acquisition deal and integration costs, which did not recur in the three months ended September 30, 2024. These cost decreases were offset by $1,462,000 of start-up costs related to the Monterrey, Mexico facility and $222,000 of current year factory and warehouse consolidation costs. Foreign currency translation had a $22,000 favorable impact on general and administrative expenses in the three months ended September 30, 2024.
Research and development expenses were $6,102,000 and $6,541,000, or 2.5% of net sales, in both the fiscal 2025 and 2024 second quarters.
Amortization of intangibles was $7,547,000 and $7,508,000 in the fiscal 2025 and 2024 second quarters, respectively, with the fluctuations related to foreign currency during the respective periods.
Interest and debt expense was $8,352,000 in the second quarter ended September 30, 2024 compared to $10,211,000 in the second quarter ended September 30, 2023. The decrease is a result of a reduction of the Company's long term debt as a result of accelerated principal payments.
Investment income of $610,000 compared to an investment loss of $88,000 in the second quarter ended September 30, 2024 and September 30, 2023. Investment income relates to the mark-to-market adjustments on the marketable securities held in the Company’s wholly owned captive insurance subsidiary and the Company's equity method investment in EMC, described in Note 6 of the financial statements.
Other (income) expense, net was $23,806,000 in the second quarter ended September 30, 2024 compared to $393,000 in the second quarter ended September 30, 2023. The increase relates to the non-cash settlement charge of $23,201,000 associated with the termination of one of the Company's U.S. pension plans in the three months ended September 30, 2024, as described in Note 10.
Income tax as a percentage of the pre-tax loss was 25% and income tax as a percentage of the pre-tax income was 24% in the second quarters ended September 30, 2024 and September 30, 2023, respectively. Typically, these percentages vary from the U.S. statutory rate of 21% primarily due to varying statutory tax rates at the Company's foreign subsidiaries, and the jurisdictional mix of income for these subsidiaries.
Six Months Ended September 30, 2024 and September 30, 2023
Net sales in the six months ended September 30, 2024 were $482,000,000, a decrease of $11,892,000 or 2.4% from the six months ended September 30, 2023 net sales of $493,892,000. Net sales were positively impacted by $7,341,000 due to price increases, $2,655,000 of revenue from the montratec acquisition, offset by $21,542,000 of unfavorable sales volume. Foreign currency translation unfavorably impacted sales by $346,000 for the six months ended September 30, 2024.
Gross profit in the six months ended September 30, 2024 was $163,773,000, a decrease of $22,853,000 or 12.2% from the six months ended September 30, 2023 gross profit of $186,626,000. Gross profit margin was 34.0% compared to 37.8% in the six months ended September 30, 2024 and 2023. The decrease in gross profit was due to start-up costs totaling $3,810,000 related to the Monterrey, Mexico facility, $10,763,000 of asset impairment and other costs related to the closure of our Charlotte Manufacturing Operations, $12,105,000 due to lower sales volume, $272,000 of net business realignment costs, and we incurred $171,000 of additional costs due to Hurricane Helene's impact on one of our facilities. These decreases were offset by $3,539,000 of price increases net of material inflation and other manufacturing costs changes and $799,000 as a result of the acquisition of montratec. The translation of foreign currencies had a $70,000 unfavorable impact on gross profit in the six months ended September 30, 2024.
Selling expenses were $54,696,000 and $51,848,000, or 11.3% and 10.5% of net sales, in the six months ended September 30, 2024 and 2023, respectively. Selling expenses increased by $909,000 related to the montratec acquisition, $802,000 primarily related to trade show and travel costs including the Company's strategic partner conference that was not held in the prior year and $635,000 of net factory and warehouse consolidation costs. The remaining increase is due to higher employee related costs during the six months ended September 30, 2024. Foreign currency translation had a $80,000 favorable impact on selling expenses in the six months ended September 30, 2024.
General and administrative expenses were $49,810,000 and $53,152,000, or 10.3% and 10.8% of net sales, in the six months ended September 30, 2024 and 2023, respectively. General and administrative expenses decreased by $3,095,000 related to prior year acquisition deal related costs which did not recur and $1,227,000 of lower net headquarter relocation costs compared to the prior year. Additionally, the Company had lower stock based compensation costs of $842,000 compared to the prior year. These cost decreases were offset by $3,314,000 of start-up costs related to the Monterrey, Mexico facility, $694,000 from the montratec acquisition and $222,000 of current year factory and warehouse consolidation costs. The remaining decrease is due to lower employee related costs during the six months ended September 30, 2024. Foreign currency translation had a $62,000 favorable impact on general and administrative expenses in the six months ended September 30, 2024.
Research and development expenses were $12,268,000 and $12,442,000, or 2.5% of net sales, in the six months ended September 30, 2024 and 2023, respectively.
Amortization of intangibles was $15,047,000 and $14,385,000 in the six months ended September 30, 2024 and 2023, respectively, with fluctuation attributable to foreign currency translation.
Interest and debt expense was $16,587,000 in the six months ended September 30, 2024 compared to $18,836,000 in the six months ended September 30, 2023. The decrease is a result of a reduction in the Company's long term debt as a result of accelerated principal payments.
Investment income of $819,000 compared to $454,000 in the six months ended September 30, 2024 and six months ended September 30, 2023. Investment income relates to the mark-to-market adjustments on the marketable securities held in the Company’s wholly owned captive insurance subsidiary and the Company's equity method investment in EMC, described in Note 6 of the financial statements.
Other (income) expense, net was $24,484,000 compared to $605,000 in the six months ended September 30, 2024 and six months ended September 30, 2023. The increase primarily relates to the non-cash settlement charge of $23,201,000 associated with the termination of one of the Company's U.S. pension plans in six months ended September 30, 2024, described in Note 10 of the financial statements
Income tax as a percentage of the pre-tax loss was 19% and income tax as a percentage of the pre-tax income was 25% in the six months ended September 30, 2024 and September 30, 2023, respectively. Typically, these percentages vary from the U.S. statutory rate of 21% primarily due to varying statutory tax rates at the Company's foreign subsidiaries, and the jurisdictional mix of income for these subsidiaries.
Liquidity and Capital Resources
Cash, cash equivalents, and restricted cash totaled $55,933,000 at September 30, 2024, a decrease of $58,443,000 from the March 31, 2024 balance of $114,376,000.
Cash flow from operating activities
Net cash used for operating activities was $1,370,000 for the six months ended September 30, 2024 compared to $558,000 for the six months ended September 30, 2023. Net loss of $6,414,000 along with non-cash adjustments to net loss of $47,222,000 contributed to cash used for operations. The non-cash adjustments included $24,028,000 of depreciation and amortization, $23,201,000 related to the settlement of one of the Company's pension plans, $5,202,000 of non-cash lease expense, $4,175,000 of stock-based compensation, and $3,268,000 related to the impairment of Charlotte Manufacturing Operation's lease. Changes in working capital reduced cash from operations by $38,472,000 as a result of an increase of $12,277,000 in inventories, an increase in prepaid expenses and other current assets of $11,714,000, a decrease of $10,711,000 in trade payables and a decrease in accrued expenses of $6,154,000, offset by a decrease in trade accounts receivable of $2,384,000. The increase in inventories relates to purchases required for expected future customer demand. Cash used for operations also included a decrease of $3,889,000 in other non-current liabilities primarily due to lease payments for the six months ended September 30, 2024.
Cash flow from investing activities
Net cash used for investing activities was $8,908,000 for the six months ended September 30, 2024 compared to $119,029,000 for the six months ended September 30, 2023. The use of cash for the six months ended September 30, 2024 primarily consisted of $10,068,000 in capital expenditures. In the six months ended September 30, 2023, the most significant use of cash in the period related to the Company's purchase of montratec for $108,145,000.
Cash flow from financing activities
Net cash used for financing activities was $47,839,000 for the six months ended September 30, 2024 and net cash provided by financing activities was $85,794,000 for the six months ended September 30, 2023. The most significant uses of cash were for $30,326,000 in debt repayments, a $6,711,000 payment to the former owners of montratec for the contingent consideration agreement (refer to Note 2 for additional information), $4,945,000 of shares repurchased as treasury stock during the quarter and a $4,038,000 dividend payment in the quarter. Cash flows from hedging activities related to the Company's cross currency swap are classified as financing activities in the Statement of Cash Flows which resulted in a net cash inflow of $53,000 during the six months ended September 30, 2024. In the six months ended September 30, 2023, the significant source of cash was $120,000,000 in gross proceeds from the issuance of long-term debt, which was used to fund the montratec acquisition.
We believe that our cash on hand, cash flows, and borrowing capacity under our Amended and Restated Credit Revolving Credit Facility will be sufficient to fund our ongoing operations and debt obligations, and capital expenditures for at least the next twelve months. This belief is dependent upon successful execution of our current business plan and effective working capital utilization. No material restrictions exist in accessing cash held by our non-U.S. subsidiaries. We expect to meet our funding needs with cash provided by our U.S. operations, as well as by repatriating non-U.S. cash. We do not expect to incur significant incremental U.S. taxes as we repatriate funds. As of September 30, 2024, $44,387,000 of cash and cash equivalents were held by foreign subsidiaries.
Refer to Note 9 for further discussion of the Company's long-term debt and financing costs.
Capital Expenditures
In addition to keeping our current equipment and plants properly maintained, we are committed to replacing, enhancing and upgrading our property, plant and equipment to support new product development, improve productivity and customer responsiveness, reduce production costs, increase flexibility to respond effectively to market fluctuations and changes, meet environmental requirements, enhance safety and promote ergonomically correct work stations. Consolidated capital expenditures for the six months ended September 30, 2024 and September 30, 2023 were $10,068,000 and $10,319,000, respectively. We expect capital expenditure spending in fiscal 2025 to range from $20,000,000 to $25,000,000.
Inflation and Other Market Conditions
Our costs are affected by inflation in the U.S. economy and, to a lesser extent, in non-U.S. economies including those of Europe, Canada, Mexico, South America, and Asia-Pacific. We do not believe that general inflation has had a material effect on our results of operations over the periods presented despite rising inflation due to our ability to pass on rising costs through price increases. In the past we have experienced higher raw material, freight, and logistics costs as a result of the COVID-19 pandemic, which we have been able to recover with pricing actions. In the future, we may not be able to pass on similar cost increases to our customers.
Goodwill Impairment Testing
We test goodwill for impairment at least annually and more frequently whenever events occur or circumstances change that indicate there may be impairment. These events or circumstances could include a significant long-term adverse change in the business climate, poor indicators of operating performance, or a sale or disposition of a significant portion of a reporting unit.
We test goodwill at the reporting unit level, which is one level below our operating segment. We identify our reporting units by assessing whether the components of our operating segment constitute businesses for which discrete financial information is available and segment management regularly reviews the operating results of those components. We also aggregate components that have similar economic characteristics into single reporting units (for example, similar products and / or services, similar long-term financial results, product processes, classes of customers, etc.). We have three reporting units: the Linear Motion Products reporting unit, the Rest of Products reporting unit, and the Precision Conveyance reporting unit, which have goodwill totaling $9,699,000, $310,300,000, and $397,983,000, respectively, as of September 30, 2024.
We currently do not believe that it is more likely than not that the fair value of any of our reporting units is less than its applicable carrying value. Additionally, we currently do not believe that we have any significant impairment indicators or that any of our reporting units with goodwill are at risk of failing Step One of the goodwill impairment test. However, if the projected long-term revenue growth rates, profit margins, or terminal growth rates are significantly lower, and/or the estimated weighted-average cost of capital is considerably higher, future testing may indicate impairment of one or more of the Company’s reporting units and, as a result, the related goodwill may be impaired.
Refer to our 2024 10-K for additional information regarding our annual goodwill impairment process.
Seasonality and Quarterly Results
Quarterly results may be materially affected by the timing of large customer orders, periods of high vacation and holiday concentrations, legal settlements, gains or losses in our portfolio of marketable securities, restructuring charges, favorable or unfavorable foreign currency translation, divestitures and acquisitions. Therefore, the operating results for any particular fiscal quarter are not necessarily indicative of results for any subsequent fiscal quarter or for the full fiscal year.
Effects of New Accounting Pronouncements
Information regarding the effects of new accounting pronouncements is included in Note 16 to the accompanying consolidated financial statements included in this Quarterly Report on Form 10-Q.
Controls and procedures
As filed, 1,227 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
As of September 30, 2024, an evaluation was performed under the supervision and with the participation of the Company’s management, including our Chief Executive Officer (the Company's principal executive officer) and Chief Financial Officer (the Company's principal financial officer), of the effectiveness of the design and operation of the Company’s disclosure controls and procedures. These disclosure controls and procedures have been designed to provide reasonable assurance that information required to be disclosed in reports filed or submitted under the Exchange Act is made known to them on a timely basis, and that such information is recorded, processed, summarized and reported within the time periods specified in the SEC’s rules and forms. Based on that evaluation, the Company’s management, including our Chief Executive Officer and Chief Financial Officer, concluded that the Company’s disclosure controls and procedures were effective as of September 30, 2024.
There have been no other changes in the Company’s internal control over financial reporting during the most recent quarter that have materially affected, or are reasonably likely to materially affect, our internal control over financial reporting.
Risk factors
As filed, 140 characters, with its headings, lists and tables. Extracted from the main document; charts and exhibits are in the original on sec.gov.
There have been no material changes from the risk factors as previously disclosed in the 2024 10-K for the fiscal year ended March 31, 2024.
Figures reported in this filing
Standardized line items from the XBRL in this filing, for the period ended 2024-09-30. Comparative periods it repeats are left out.
| Line item | Period | Value | XBRL concept |
|---|---|---|---|
| Revenue | 3 months2024-07-01 to 2024-09-30 | $242.3m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Revenue | 6 months2024-04-01 to 2024-09-30 | $482.0m | us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax |
| Cost of revenue | 3 months2024-07-01 to 2024-09-30 | $167.5m | us-gaap:CostOfGoodsAndServicesSold |
| Cost of revenue | 6 months2024-04-01 to 2024-09-30 | $318.2m | us-gaap:CostOfGoodsAndServicesSold |
| Gross profit | 3 months2024-07-01 to 2024-09-30 | $74.7m | us-gaap:GrossProfit |
| Gross profit | 6 months2024-04-01 to 2024-09-30 | $163.8m | us-gaap:GrossProfit |
| Research and development | 3 months2024-07-01 to 2024-09-30 | $6.1m | us-gaap:ResearchAndDevelopmentExpense |
| Research and development | 6 months2024-04-01 to 2024-09-30 | $12.3m | us-gaap:ResearchAndDevelopmentExpense |
| Operating income | 3 months2024-07-01 to 2024-09-30 | $10.8m | us-gaap:OperatingIncomeLoss |
| Operating income | 6 months2024-04-01 to 2024-09-30 | $32.0m | us-gaap:OperatingIncomeLoss |
| Income tax | 3 months2024-07-01 to 2024-09-30 | −$4.9m | us-gaap:IncomeTaxExpenseBenefit |
| Income tax | 6 months2024-04-01 to 2024-09-30 | −$1.5m | us-gaap:IncomeTaxExpenseBenefit |
| Net income | 3 months2024-07-01 to 2024-09-30 | −$15.0m | us-gaap:NetIncomeLoss |
| Net income | 6 months2024-04-01 to 2024-09-30 | −$6.4m | us-gaap:NetIncomeLoss |
| Diluted EPS | 3 months2024-07-01 to 2024-09-30 | −$0.52 | us-gaap:EarningsPerShareDiluted |
| Diluted EPS | 6 months2024-04-01 to 2024-09-30 | −$0.22 | us-gaap:EarningsPerShareDiluted |
| Basic EPS | 3 months2024-07-01 to 2024-09-30 | −$0.52 | us-gaap:EarningsPerShareBasic |
| Basic EPS | 6 months2024-04-01 to 2024-09-30 | −$0.22 | us-gaap:EarningsPerShareBasic |
| Diluted shares (weighted) | 3 months2024-07-01 to 2024-09-30 | 28,869,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Diluted shares (weighted) | 6 months2024-04-01 to 2024-09-30 | 28,852,000 shares | us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding |
| Operating cash flow | 6 months2024-04-01 to 2024-09-30 | −$1.4m | us-gaap:NetCashProvidedByUsedInOperatingActivities |
| Capital expenditure | 6 months2024-04-01 to 2024-09-30 | $10.1m | us-gaap:PaymentsToAcquirePropertyPlantAndEquipment |
| Dividends paid | 6 months2024-04-01 to 2024-09-30 | $4.0m | us-gaap:PaymentsOfDividends |
| Share repurchases | 6 months2024-04-01 to 2024-09-30 | $4.9m | us-gaap:PaymentsForRepurchaseOfCommonStock |
| Cash and equivalents | At period end2024-09-30 | $55.7m | us-gaap:CashAndCashEquivalentsAtCarryingValue |
| Current assets | At period end2024-09-30 | $467.7m | us-gaap:AssetsCurrent |
| Total assets | At period end2024-09-30 | $1.78bn | us-gaap:Assets |
| Current liabilities | At period end2024-09-30 | $229.7m | us-gaap:LiabilitiesCurrent |
| Total liabilities | At period end2024-09-30 | $880.8m | us-gaap:Liabilities |
| Current portion of debt | At period end2024-09-30 | $50.0m | us-gaap:LongTermDebtCurrent |
| Shareholders' equity | At period end2024-09-30 | $896.1m | us-gaap:StockholdersEquity |
Source: SEC EDGAR, the filing index for accession 0001005229-24-000284. Last ingested by Listed: Nov 3, 2026, 19:38 ET. Listed shows no prices and gives no investment advice.